Company news
Avalo Therapeutics, Inc. news in 2022
Avalo Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Avalo Sells Economic Rights to Previously Out-Licensed Assets for $5 Million
November 6, 2022
Avalo Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 6, 2022
Avalo Advances BTLA Agonist Fusion Protein (AVTX-008) to IND-enabling Stage
September 5, 2022
Avalo to Present at the H.C. Wainwright Global Investment Conference
August 31, 2022
Avalo Therapeutics Announces Board Changes
August 10, 2022
Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates
August 3, 2022
Avalo Therapeutics Announces First Patient Dosed in the AVTX-803 Pivotal Trial (LADDER) for the Treatment of Leukocyte Adhesion Deficiency Type II (LAD II)
August 1, 2022
Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics
July 31, 2022
Avalo Therapeutics Announces One-for-Twelve Reverse Stock Split
July 5, 2022
Avalo to Present at the 2022 Jefferies Healthcare Conference
June 1, 2022
Avalo Therapeutics Announces First Patient Dosed in the Phase 2 PEAK Trial of AVTX-002 for the Treatment of Non-Eosinophilic Asthma (NEA)
May 17, 2022
Avalo to Present at the H.C. Wainwright Global Life Sciences Conference
May 16, 2022
Avalo Therapeutics First Quarter 2022 Financial Results and Business Updates
May 4, 2022
Avalo to Present at Oppenheimer's 32nd Annual Healthcare Conference
March 7, 2022
Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates
March 1, 2022
Avalo Therapeutics Announces Leadership Transition
February 16, 2022
Avalo Therapeutics to Present at the 2022 BIO CEO and Investor Conference
February 6, 2022
Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer
January 9, 2022
Avalo Reports Positive Phase 1b Results for AVTX-002 in Moderate to Severe Crohn's Disease Patients and Presents Additional Program Updates at 2022 Investor Event
January 5, 2022
Decks in 2022
- Investor Presentation (August 2022)
Investor deck · 26 slides · Aug 16, 2022
- Investor Presentation (May 2022)
Investor deck · 22 slides · May 24, 2022
- Investor Presentation (March 2022)
Investor deck · 22 slides · Mar 16, 2022
- Investor Day (January 2022)
Investor day · 50 slides · Jan 6, 2022